Connect with us

Health

South African variant can ‘break through’ Pfizer vaccine, Israeli study says – Reuters

The coronavirus variant discovered in South Africa can “break through” Pfizer/BioNTech’s COVID-19 vaccine to some extent, a real-world data study in Israel found,…

Published

on

Article feature image

By Maayan Lubell
JERUSALEM (Reuters) – The coronavirus variant discovered in South Africa can break through Pfizer/BioNTechs COVID-19 vaccine to some extent, a real-world data study in Israel found, though its prevalence in the country is low and the research has not been peer reviewed.
The study, released on Saturday, compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated patients…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending